ANVS
Annovis Bio Inc
1.20$
+2.5%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2009 | 2010 | 2011 | 2012 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 8.0% | 59.3% | 62.3% | 56.2% | 100.0% | 100.0% | 66.9% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 2.1% | 20.0% | 6.6% | 2.6% | 97.1% | 69.3% | 0.2% | 99.4% | 99.3% | 78.8% | 56.4% | 75.8% | 92.7% | |
| – | – | – | – | 97.1% | 69.3% | 0.2% | 99.4% | 99.3% | 78.8% | 56.4% | 75.8% | 92.7% | |
| 0.2% | 15.2% | 24.0% | 52.0% | – | – | 65.8% | – | – | – | – | – | – | |
| 5.4% | 20.4% | 25.0% | 0.8% | – | – | -66,747.7% | – | – | – | – | – | – | |
| 1.4% | 3.5% | 3.0% | 2.3% | – | – | – | – | – | – | – | – | – | |
| – | 28.5% | 20.0% | – | – | – | – | – | – | – | – | – | – | |
| 90.7% | 5.5% | 8.1% | 41.5% | – | – | – | – | – | – | – | – | – | |
| 3.0% | 25.2% | 33.7% | 6.1% | 2,045.9% | 14,992.3% | 867.7% | 7.1% | 3.3% | 21.4% | 175.9% | 33.2% | 20.1% | |
| 3.0% | 25.2% | 33.7% | 6.1% | 136.9% | 1,113.8% | 180.0% | 7.1% | 3.3% | 21.4% | 41.9% | 27.9% | 17.2% | |
| 0.5% | 23.7% | 33.2% | 6.1% | 19.9% | 134.2% | 110.5% | 4.2% | 1.5% | 11.0% | 12.7% | 16.6% | 12.3% | |
| – | – | – | – | – | – | 44.7% | – | – | – | – | – | – | |
| 97.0% | 74.8% | 66.3% | 93.9% | -1,945.9% | -14,892.3% | -767.7% | 92.9% | 96.7% | 78.6% | -75.9% | 66.8% | 79.9% | |
| -48.6% | -8.7% | -31.8% | -529.1% | -1,975.7% | -15,269.2% | -785.7% | -175.4% | -62.4% | -150.1% | -1,080.1% | -968.4% | -776.5% | |
| – | – | – | – | 1,904.7% | 13,371.1% | 612.8% | 77.7% | 16.6% | 22.7% | 88.4% | 87.9% | 97.5% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.